HRT FINANCIAL LP - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 24 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$649
-99.9%
64,9800.0%0.01%
+28.6%
Q3 2022$644,000
+0.9%
64,9800.0%0.01%0.0%
Q2 2022$638,000
-0.5%
64,9800.0%0.01%
+40.0%
Q1 2022$641,000
-1.5%
64,9800.0%0.01%
+25.0%
Q4 2021$651,000
+0.3%
64,9800.0%0.00%0.0%
Q3 2021$649,000
-0.6%
64,9800.0%0.00%
-33.3%
Q2 2021$653,000
+2.0%
64,9800.0%0.01%0.0%
Q1 2021$640,00064,9800.01%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,914,250,0003.01%
Wealthspring Capital LLC 277,192$2,786,0000.70%
BASSO CAPITAL MANAGEMENT, L.P. 135,404$1,361,0000.17%
Omni Partners US LLC 364,371$3,662,0000.16%
Sage Mountain Advisors LLC 93,470$939,0000.16%
Castle Creek Arbitrage, LLC 253,446$2,540,0000.14%
Shaolin Capital Management LLC 396,200$3,982,0000.12%
Context Capital Management, LLC 115,053$1,156,0000.11%
PERISCOPE CAPITAL INC. 250,000$2,512,0000.08%
Magnetar Financial LLC 803,400$8,074,0000.08%
View complete list of IBERE PHARMACEUTICALS shareholders